Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD PhD, Alina V. Kokhno, MD PhD, Zalina T. Fidarova, MD PhD, Olga A. Gavrilina, MD PhD, Tatiana I. Lobanova, MD, Elena O. Gribanova, MD PhD, Sergey K. Kravchenko, MD PhD, Gennadiy M. Galstyan, MD PhD, Sergei M. Kulikov, PhD, Julia A. Chabaeva, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5136.

https://doi.org/10.1182/blood-2019-124056

Published: 2019

Journal Articles

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Blood (2019) 134 (Supplement_1): 5072.

https://doi.org/10.1182/blood-2019-124701

Published: 2019

Journal Articles

Loss of Heterozygosity in the Short Tandem Repeat (STR) Loci Found in Tumor DNA of De Novo Diagnosed ALL Patients As a Factor Predicting Poor Outcome

Natalya V Risinskaya, PhD, Olga A. Gavrilina, MD PhD, Julia A. Chabaeva, Anna Yushkova, Andrey B Sudarikov, PhD DSc, Sergei M. Kulikov, PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5204.

https://doi.org/10.1182/blood-2019-126668

Published: 2019

Journal Articles

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Blood (2018) 132 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2018-99-116318

Published: 2018

Journal Articles

High-Grade Diffuse Large B-Cell Lymphoma in Elderly Patients: Russian Multicenter Trial Results in R-EPOCH/R-HMA Protocol

Olga A. Gavrilina, MD PhD, Eugene E. Zvonkov, MD PhD, Elena N. Parovichnikova, MD PhD, Nelly G. Gabeeva, PhD, Vera V. Troitskaya, MD PhD, Inessa Yu. Toropova, Andrey V. Gubkin, Vitalii S. Kanin, Valery A. Lapin, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5386.

https://doi.org/10.1182/blood.V128.22.5386.5386

Published: 2016

Journal Articles

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Eugene E. Zvonkov, MD PhD, Nelly G. Gabeeva, PhD, Anna K. Morozova, Olga A. Gavrilina, MD PhD, Anna A. Sidorova, MD, Daria A. Koroleva, MD, Tatiana N. Obukhova, PhD, Alla Kovrigina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5388.

https://doi.org/10.1182/blood.V128.22.5388.5388

Published: 2016

Journal Articles

Pregnancy Is a Poor Prognostic Factor for AML Outcome

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD PhD, Alina Kokhno, MD, PhD, Zalina T. Fidarova, Anna A. Sidorova, MD, Olga A. Gavrilina, MD PhD, Gennadii M. Galstian, MD PhD, Aleksei Bazhenov, MD, Larisa A. Kuzmina, MD PhD, Mikhail Yu. Drokov, MD PhD, Sergei Makhinya, Oleg Latishkevich, Alexandra Zvereva, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5171.

https://doi.org/10.1182/blood.V128.22.5171.5171

Published: 2016

NARROW

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Loss of Heterozygosity in the Short Tandem Repeat (STR) Loci Found in Tumor DNA of De Novo Diagnosed ALL Patients As a Factor Predicting Poor Outcome

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

High-Grade Diffuse Large B-Cell Lymphoma in Elderly Patients: Russian Multicenter Trial Results in R-EPOCH/R-HMA Protocol

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Pregnancy Is a Poor Prognostic Factor for AML Outcome

Email alerts

ASH Publications

American Society of Hematology

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Loss of Heterozygosity in the Short Tandem Repeat (STR) Loci Found in Tumor DNA of De Novo Diagnosed ALL Patients As a Factor Predicting Poor Outcome

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

High-Grade Diffuse Large B-Cell Lymphoma in Elderly Patients: Russian Multicenter Trial Results in R-EPOCH/R-HMA Protocol

Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience

Pregnancy Is a Poor Prognostic Factor for AML Outcome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only